mRNA Flu Shot Moves Forward As Pfizer Launches Late-Stage Trial, Builds On Covid Vaccine Success

Pfizer hopes to use the mRNA technology used in its Covid-19 vaccine to build a more effective flu shot.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive